John B Taylor

Expanding the landscape of covalent drug discovery: irreversible targeting of non-cysteine residues.

This review explores the outstanding questions and challenges in developing covalent inhibitors beyond cysteine, highlighting current warhead chemistries, strategies for achieving selectivity, proteomic mapping advances, assessment of the intrinsic reactivity of the electrophiles targeting non-cysteine residues and opp...